337 related articles for article (PubMed ID: 19428913)
1. Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy.
Demento SL; Eisenbarth SC; Foellmer HG; Platt C; Caplan MJ; Mark Saltzman W; Mellman I; Ledizet M; Fikrig E; Flavell RA; Fahmy TM
Vaccine; 2009 May; 27(23):3013-21. PubMed ID: 19428913
[TBL] [Abstract][Full Text] [Related]
2. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome.
Sharp FA; Ruane D; Claass B; Creagh E; Harris J; Malyala P; Singh M; O'Hagan DT; Pétrilli V; Tschopp J; O'Neill LA; Lavelle EC
Proc Natl Acad Sci U S A; 2009 Jan; 106(3):870-5. PubMed ID: 19139407
[TBL] [Abstract][Full Text] [Related]
3. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants.
Eisenbarth SC; Colegio OR; O'Connor W; Sutterwala FS; Flavell RA
Nature; 2008 Jun; 453(7198):1122-6. PubMed ID: 18496530
[TBL] [Abstract][Full Text] [Related]
4. Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants.
Marty-Roix R; Vladimer GI; Pouliot K; Weng D; Buglione-Corbett R; West K; MacMicking JD; Chee JD; Wang S; Lu S; Lien E
J Biol Chem; 2016 Jan; 291(3):1123-36. PubMed ID: 26555265
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3.
Li H; Willingham SB; Ting JP; Re F
J Immunol; 2008 Jul; 181(1):17-21. PubMed ID: 18566365
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome.
Kool M; Pétrilli V; De Smedt T; Rolaz A; Hammad H; van Nimwegen M; Bergen IM; Castillo R; Lambrecht BN; Tschopp J
J Immunol; 2008 Sep; 181(6):3755-9. PubMed ID: 18768827
[TBL] [Abstract][Full Text] [Related]
7. Rational design of nanoparticles towards targeting antigen-presenting cells and improved T cell priming.
Zupančič E; Curato C; Paisana M; Rodrigues C; Porat Z; Viana AS; Afonso CAM; Pinto J; Gaspar R; Moreira JN; Satchi-Fainaro R; Jung S; Florindo HF
J Control Release; 2017 Jul; 258():182-195. PubMed ID: 28511928
[TBL] [Abstract][Full Text] [Related]
8. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
9. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ
J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430
[TBL] [Abstract][Full Text] [Related]
10. TLR agonists stimulate Nlrp3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo.
He Y; Franchi L; Núñez G
J Immunol; 2013 Jan; 190(1):334-9. PubMed ID: 23225887
[TBL] [Abstract][Full Text] [Related]
11. NLRP3 inflammasome-activating arginine-based liposomes promote antigen presentations in dendritic cells.
Li T; Zehner M; He J; Próchnicki T; Horvath G; Latz E; Burgdorf S; Takeoka S
Int J Nanomedicine; 2019; 14():3503-3516. PubMed ID: 31190807
[No Abstract] [Full Text] [Related]
12. Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59.
Ellebedy AH; Lupfer C; Ghoneim HE; DeBeauchamp J; Kanneganti TD; Webby RJ
Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2927-32. PubMed ID: 21270336
[TBL] [Abstract][Full Text] [Related]
13. Activation of the NLRP3 inflammasome is not a feature of all particulate vaccine adjuvants.
Neumann S; Burkert K; Kemp R; Rades T; Rod Dunbar P; Hook S
Immunol Cell Biol; 2014 Jul; 92(6):535-42. PubMed ID: 24687021
[TBL] [Abstract][Full Text] [Related]
14. TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis.
Demento SL; Bonafé N; Cui W; Kaech SM; Caplan MJ; Fikrig E; Ledizet M; Fahmy TM
J Immunol; 2010 Sep; 185(5):2989-97. PubMed ID: 20660705
[TBL] [Abstract][Full Text] [Related]
15. A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations.
Van Hoeven N; Joshi SW; Nana GI; Bosco-Lauth A; Fox C; Bowen RA; Clements DE; Martyak T; Parks DE; Baldwin S; Reed SG; Coler RN
PLoS One; 2016; 11(2):e0149610. PubMed ID: 26901122
[TBL] [Abstract][Full Text] [Related]
16. Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles.
Sun B; Ji Z; Liao YP; Wang M; Wang X; Dong J; Chang CH; Li R; Zhang H; Nel AE; Xia T
ACS Nano; 2013 Dec; 7(12):10834-49. PubMed ID: 24261790
[TBL] [Abstract][Full Text] [Related]
17. Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.
Hafner AM; Corthésy B; Merkle HP
Adv Drug Deliv Rev; 2013 Oct; 65(10):1386-99. PubMed ID: 23751781
[TBL] [Abstract][Full Text] [Related]
18. Supramolecular peptide hydrogel adjuvanted subunit vaccine elicits protective antibody responses against West Nile virus.
Friedrich BM; Beasley DWC; Rudra JS
Vaccine; 2016 Nov; 34(46):5479-5482. PubMed ID: 27670075
[TBL] [Abstract][Full Text] [Related]
19. TLR3- and MyD88-dependent signaling differentially influences the development of West Nile virus-specific B cell responses in mice following immunization with RepliVAX WN, a single-cycle flavivirus vaccine candidate.
Xia J; Winkelmann ER; Gorder SR; Mason PW; Milligan GN
J Virol; 2013 Nov; 87(22):12090-101. PubMed ID: 23986602
[TBL] [Abstract][Full Text] [Related]
20. Inflammasome recognition of influenza virus is essential for adaptive immune responses.
Ichinohe T; Lee HK; Ogura Y; Flavell R; Iwasaki A
J Exp Med; 2009 Jan; 206(1):79-87. PubMed ID: 19139171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
